Horizon Pharma plc Submits Investigational New Drug Application for ACTIMMUNE® in the Treatment of Friedreich's Ataxia
. Marketwired, February 13, 2015
SOURCE: Horizon Pharma plc
Phase 3 Study Expected to Begin in Q2 2015
Friday, February 13, 2015
PIPs in neurological diseases
PIPs in neurological diseases. M.G. Waugh, Biochim. Biophys. Acta (2015), http://dx.doi.org/10.1016/j.bbalip.2015.02.002
There has been an interesting development recently concerning the possible involvement of PIP5K1B in Friedreich's ataxia.
There has been an interesting development recently concerning the possible involvement of PIP5K1B in Friedreich's ataxia.
Subscribe to:
Posts (Atom)
